We are live on
!
Find out more
PFO
Pathstone Family Office Portfolio holdings
AUM
$13.1B
1-Year Est. Return
21.02%
This Fund
S&P 500
This Quarter
Est. Return
+3.12%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$848M
AUM Growth
+$61.7M
(+7.8%)
Cap. Flow
+$46.7M
Cap. Flow
% of AUM
5.51%
Top 10 Holdings %
Top 10 Hldgs %
57.15%
Holding
999
New
86
Increased
189
Reduced
130
Closed
344
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$10.4M |
| 2 |
TJX Companies
TJX
|
+$8.24M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$4.03M |
| 4 |
Apple
AAPL
|
+$3.4M |
| 5 |
CarGurus
CARG
|
+$2.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$3.89M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.15M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.05M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.58M |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.85% |
| 2 | Technology | 11.23% |
| 3 | Consumer Discretionary | 9.7% |
| 4 | Communication Services | 3.67% |
| 5 | Industrials | 3.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Eli Lilly
LLY
$1.02T
| $734K | 0.09% |
6,638
-48
| -0.7% | -$5.65K |
|
102
Allogene Therapeutics
ALLO
$649M
| $732K | 0.09% |
+27,250
| New | +$759K |
|
103
Chubb
CB
$135B
| $721K | 0.09% |
4,890
+428
| +10% | +$61.8K |
|
104
IBM
IBM
$211B
| $719K | 0.08% |
5,445
+720
| +15% | +$94.6K |
|
105
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $719K | 0.08% |
6,543
-2,363
| -27% | -$253K |
|
106
GE Aerospace
GE
$374B
| $717K | 0.08% |
13,672
+1,247
| +10% | +$61.4K |
|
107
American Airlines Group
AAL
$10.1B
| $707K | 0.08% |
21,693
| – | – |
|
108
PayPal
PYPL
$48.9B
| $702K | 0.08% |
6,144
+5,312
| +638% | +$589K |
|
109
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $693K | 0.08% |
17,805
+1,595
| +10% | +$61.1K |
|
110
Adobe
ADBE
$99.5B
| $692K | 0.08% |
2,349
+352
| +18% | +$97.8K |
|
111
Boeing
BA
$171B
| $692K | 0.08% |
1,903
-1,584
| -45% | -$578K |
|
112
Boston Scientific
BSX
$69.5B
| $648K | 0.08% |
15,091
+5,000
| +50% | +$192K |
|
113
PepsiCo
PEP
$190B
| $627K | 0.07% |
4,773
+1,314
| +38% | +$168K |
|
114
Elevance Health
ELV
$81.5B
| $624K | 0.07% |
2,210
+619
| +39% | +$169K |
|
115
Dollar Tree
DLTR
$24.4B
| $622K | 0.07% |
5,795
+75
| +1% | +$7.89K |
|
116
Marathon Petroleum
MPC
$92.4B
| $622K | 0.07% |
11,100
+1,000
| +10% | +$54.7K |
|
117
Humana
HUM
$43.7B
| $611K | 0.07% |
+2,300
| New | +$583K |
|
118
AbbVie
ABBV
$443B
| $595K | 0.07% |
8,164
+1,282
| +19% | +$101K |
|
119
KeyCorp
KEY
$24.2B
| $593K | 0.07% |
33,438
+4,805
| +17% | +$81.3K |
|
|
RTN
120
DELISTED
Raytheon Company
RTN
| $587K | 0.07% |
3,375
-33
| -1% | -$5.94K |
|
121
Chevron
CVX
$392B
| $576K | 0.07% |
4,630
+623
| +16% | +$75.3K |
|
122
Pfizer
PFE
$143B
| $573K | 0.07% |
13,920
-226
| -2% | -$8.97K |
|
123
Amplify BlueStar Israel Technology ETF
ITEQ
$112M
| $572K | 0.07% |
14,705
| – | – |
|
124
Walmart Inc
WMT
$885B
| $571K | 0.07% |
15,525
-84
| -0.5% | -$2.9K |
|
125
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.69B
| $563K | 0.07% |
11,955
+2,250
| +23% | +$105K |
|
Similar funds
CG
API
TA
SCH
PWAG
CS
IWP
MAM
Pathstone Family Office's Q2 2019 Portfolio in Review
As of Q2 2019, Pathstone Family Office held 999 positions worth $848M, up 7.8% from $786M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Pathstone Family Office deployed $46.7M of net new capital in Q2 2019, opening 86 new positions and adding to 189 existing holdings. Its largest new stake was Primerica: 18,415 shares worth $2.21M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Merck, an estimated $3.89M trimmed.
- Pathstone Family Office's largest Q2 2019 buy was Primerica: 18,415 shares worth $2.21M.
- Pathstone Family Office added most to iShares Russell 1000 ETF in Q2 2019, an estimated $10.4M increase.
- Pathstone Family Office's biggest Q2 2019 reduction was Merck, cutting an estimated $3.89M.
- Pathstone Family Office fully exited Xylem in Q2 2019, selling an estimated $983K.
- Pathstone Family Office's ten largest holdings make up 57% of its $848M portfolio in Q2 2019.
- Pathstone Family Office opened 86 new positions and closed 344 in Q2 2019.
- Pathstone Family Office's portfolio value rose 7.8% quarter-over-quarter to $848M.
Based on Pathstone Family Office's 13F filing for Q2 2019, filed 14 Aug 2019.